Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Tumor × Everolimus × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 7 Endometrial Neoplasms 4 Neuroendocrine Tumors 3 Carcinoma, Renal Cell 3 Tuberous Sclerosis 2 Recurrence 2 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Solid Tumor 1 Seizures 1 Sarcoma 1 Primary Non-metastatic Breast Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Endometrial Hyperplasia 1 Clear-cell metastatic renal cell carcinoma 1 Breast Neoplasms, Male 1 Angiomyolipoma 1 Advanced Solid Tumors 1 Advanced Cancer 1

Interventions

pembrolizumab 2 zimberelimab 1 tislelizumab 1 tilsotolimod 1 sintilimab 1 sacituzumab govitecan 1 niraparib 1 cobimetinib 1 cedazuridine 1 atezolizumab 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Injections 1 Everolimus 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡